Armata Pharmaceuticals Inc (ARMP)
2.45
-0.23
(-8.58%)
USD |
NYAM |
Nov 15, 12:47
Armata Pharmaceuticals Net Income (TTM): -67.04M for June 30, 2024
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | -67.04M |
| March 31, 2024 | -79.58M |
| December 31, 2023 | -69.04M |
| September 30, 2023 | -59.51M |
| June 30, 2023 | -36.96M |
| March 31, 2023 | -42.63M |
| December 31, 2022 | -36.92M |
| September 30, 2022 | -32.65M |
| June 30, 2022 | -29.46M |
| March 31, 2022 | -26.43M |
| December 31, 2021 | -23.16M |
| September 30, 2021 | -23.73M |
| June 30, 2021 | -24.08M |
| March 31, 2021 | -22.60M |
| December 31, 2020 | -22.18M |
| September 30, 2020 | -20.14M |
| June 30, 2020 | -21.33M |
| March 31, 2020 | -20.82M |
| December 31, 2019 | -19.48M |
| September 30, 2019 | -11.40M |
| June 30, 2019 | -7.218M |
| March 31, 2019 | -6.069M |
| December 31, 2018 | -5.464M |
| September 30, 2018 | -11.31M |
| June 30, 2018 | -9.315M |
| Date | Value |
|---|---|
| March 31, 2018 | -12.73M |
| December 31, 2017 | -12.84M |
| September 30, 2017 | -19.99M |
| June 30, 2017 | -21.58M |
| March 31, 2017 | -18.97M |
| December 31, 2016 | -18.84M |
| September 30, 2016 | -11.57M |
| June 30, 2016 | -3.755M |
| March 31, 2016 | 10.86M |
| December 31, 2015 | -0.516M |
| September 30, 2015 | 1.051M |
| June 30, 2015 | 16.82M |
| March 31, 2015 | 19.92M |
| December 31, 2014 | 23.11M |
| September 30, 2014 | 24.23M |
| June 30, 2014 | -45.73M |
| March 31, 2014 | -74.24M |
| December 31, 2013 | -64.58M |
| September 30, 2013 | -64.37M |
| June 30, 2013 | -8.307M |
| March 31, 2013 | 4.552M |
| September 30, 2009 | -4.652M |
| June 30, 2009 | -7.984M |
| March 31, 2009 | -19.09M |
| December 31, 2008 | -20.72M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-79.58M
Minimum
Mar 2024
-19.48M
Maximum
Dec 2019
-35.67M
Average
-26.43M
Median
Mar 2022
Net Income (TTM) Benchmarks
| AIM ImmunoTech Inc | -28.04M |
| Perspective Therapeutics Inc | -59.02M |
| Protalix BioTherapeutics Inc | -14.69M |
| Electromed Inc | 5.15M |
| Xtant Medical Holdings Inc | -3.333M |